Skip to main content

Today's Cannabis Economic News (2026-08-29 JST)

News SummaryThis article summarizes the key points by organizing the updates from multiple sources.
Published 2026.08.29Updated 2026.08.29 05:39
Today's Cannabis Economic News (2026-08-29 JST)

We have focused on the dynamic figures of the market and regulations, organizing them to provide a comprehensive overview of the information needed for investment and business decisions.

概況

Developments regarding U.S. federal regulatory reform continue to influence market sentiment, particularly the DEA's...2,533 pageThe extensive public hearing records have caused a stir, influencing the trading volume and price movements of ETFs and individual stocks (2,533 pages = 500 sheets of A4 paper).Approximately 5 books(The sense of volume).
Meanwhile, in state markets, delays in Kentucky's supply have become apparent. In Europe, in the UK...More than 22% THCMedical cannabis85 %The prescription structure clearly favors high-potency drugs, accounting for a large proportion of the market. In the Netherlands, policy responses regarding the potential influence of major tobacco companies were presented, bringing to light issues of capital policy. In Japan, for senior dogs...CBDOpportunities for awareness-raising and experiential learning are expanding.

Market and Stock Trends

MSOS and individual stock performance: "Prices were set, but trading volume was thin."

  • Sector ETFsMSOStemporary$5 levelAfter recovering, the closing priceAround $4.85The volume wasApproximately 500 million sharesSo, despite the price fluctuations,The portion size is not enough.The view was expressed that the ratio of 500 million is "compared to a city population of 1000 million."約半分This number represents a scale equivalent to "[...]" (this is just an illustration).
  • Trulieve The$11.85After rising to that point,$11.43Close it nearby. RecentlyListing market change (uplisting)This has been analyzed as a factor making it easier for investors who do not have access to OTC (over-the-counter) trading to buy the stock.

In an investor comment (from FundCanna CEO Adam Stettner), MSOS has "outperformed many segments" in the past month,Low trading volume raises concerns about sustainability.He pointed this out. It appears they are waiting for the next regulatory move.
(https://thedalesreport.com/cannabis/psychedelic-medicine-gets-federal-attention-cbd-program-update/ and others, https://thedalesreport.com/cannabis/why-dea-came-out-guns-blazing-for-reform/)

Index/StockPrice movementsVolume and related figuresSuggestion
MSOSTemporarily over $5 → around $4.85Approximately 500 million sharesPrices have been set, but trading is light; we are waiting for confirmation of the system reform.
TrulieveHigh of $11.85 → around $11.43 Uplisting contributes to improved supply and demand

Regulation/Policy

The US DEA's rescheduling debate: The pros and cons of shifting from five requirements to two.

  • The public hearing records are2,533 page.
  • The biggest point of opposition is "historical5要件から2要件The transition to the new standards stems from an opinion by the Office of Legal Counsel (OLC) stating that the five requirements for botanicals were excessively narrow.
  • StillThe probability of a Schedule III recommendation is over 70%.This is the view (Stettner).Abuse potential is lower than that of tobacco and alcohol.The DEA's understanding of the situation was also mentioned.
From a behavioral economics perspective, "expectations (expected utility)" influence investors' decision-making. While a 70% certainty figure for regulations can easily create a bias towards overestimating future benefits, it's crucial to consider whether current data such as "trading volume" supports those expectations with actual demand.
Glossary: ​​"Rescheduling (reclassification)" = Reviewing drug regulations and classifying them according to their medical use and risk of abuse.Tax burden, research permits, and listing restrictionsChanges in economic conditions such as these.

(https://thedalesreport.com/cannabis/why-dea-came-out-guns-blazing-for-reform/)

Netherlands: Tobacco capital and "experimental cultivation"—the limitations of capital regulation are exposed.

  • major tobacco companiesAltria owns 41% of Cronos.(Minority shareholders).
  • CronosCane EagleIn connection with the acquisition, the governmentThere is no legal basis to exclude shareholders.They responded that while the possibility of policy involvement "cannot be ruled out," direct blocking under the current system would be difficult.

41% said "of 10 sharesAbout 4 stocksThe scale of this is significant. Capital inflows from existing industries bring the risk of market dominance, in exchange for price and supply stability.
(https://cannabisindustrie.nl/kabinet-inmenging-tabaksindustrie-wietexperiment/)

Americas Market: Kentucky's Medical Marijuana Supply Bottleneck

  • From legalization in 2023Approximately 20 monthsSo, the businesses that are currently operating are39 companiesStay within.
  • MMJ cardholders stillDifficulty in obtaining productsFaced with this.

The number "39" is, in light of state-level healthcare needs...“Supply constraints in the initial stages”This suggests that delays in licensing areThe cost of holding start-up capitalor local government responseCompliance expensesThis could also be a factor that pushes it up.
(https://mjbizdaily.com/news/supply-shortages-licensing-delays-slow-kentuckys-mmj-market/617809/)

Company/industry trends

Discussions on improving access and security for major US institutional investors

  • TrulieveUplistingAs a result, trading restrictions for institutional investors and some individual investors are eased, and the quality of supply and demand improves.
  • NuggMD's weekly survey on safety (513) So,Stricter inspection standards"But40 %This was the most frequent response. The runner-up was "clearer education."

Strengthening testing is a short-term measure.COGS (Cost of Goods Sold) riseWhile attracting,Price premium,Avoiding recall and litigation costsThis will support your long-term earning potential.
(https://thedalesreport.com/cannabis/psychedelic-medicine-gets-federal-attention-cbd-program-update/)

Japan: Pet CBD "Cansuna" - Expanding opportunities for use in senior dog care

  • Tatsumi Publishing, "Happy Senior Dog Life"Released on November 7) Featured in [publication name].
  • November 16stWe will conduct seminars for professionals.CBD starter pack availableIn collaboration with the Japan Animal CBD Association, etc.,ECS (Endocannabinoid System)To promote understanding of this.
Glossary: ​​The endocrine system (ECS) is a mechanism involved in maintaining homeostasis in the body, and it is present in humans, dogs, and cats.
The key to the marketing strategy is "education x experience." For new categories, starter packs that reduce the cost of the experience are effective in creating demand.

(https://prtimes.jp/main/html/rd/p/000000015.000121464.html)

Overseas market data

UK: Medical flowers are becoming increasingly high in THC.

  • More than 22% THCThe prescription85% by 2026This represents a significant increase from the initial estimate of "about half" for 2025.
  • 2025 data73,605 ofMinutes were added and captured.Upward revision.
  • The degree of prescription concentration (bias towards top prescribing physicians)Greatly decreasedThis suggests an expansion of the market participant base.

"85%"100件中85件This illustrates the reality that the medical market is shifting towards high-potency products. The overemphasis on high THC isPrice formation (value per mg),Insurance and safety standardsThe potential ripple effects are a key investment point.
(https://businessofcannabis.com/majority-of-uk-medical-cannabis-flower-now-at-25-thc-or-above-new-data-shows/)

Research/social implications

The role of the "endogenous cannabinoid system" as revealed by placebo-nocebo studies.

  • Placebo analgesia affects the prefrontal cortex-cingulate gyrus and descending analgesia (periaqueductal gray matter, ventral rostral part of the medulla oblongata),Opioids / Dopamine / CannabinoidsThe involvement of the system is shown.
  • Nocebo is involved in pain stimulation through stress-related systems and gallbladder contraction hormone (CCK).
Neuroscience findings indicate that patient experience (expectations and context) influences analgesic effects. In clinical practice with medical cannabis, in addition to pharmacological effects, "explanation and environmental design" can also affect outcomes and cost-effectiveness.
Glossary: ​​Placebo = The phenomenon where symptoms are alleviated due to the expectation that the treatment might work. Nocebo = The phenomenon where symptoms worsen due to anxiety about the possibility of side effects.

(https://pubmed.ncbi.nlm.nih.gov/42661597/)

Extreme heat and emergency medical services—"Cannabinoid-related mental and behavioral disorders" also included in the related diagnostic group.

  • Chicago Emergency and Critical Care26,883 itemsWe analyzed data from 2011–2023 and found significant correlations with extreme heat.33 diagnosesIdentify.
  • In itCannabinoid-related mental and behavioral disordersIt has been reported that this is also included.

Outdoor events and peak tourist seasonRisk management costsThis has implications for insurance rates and drug testing systems. Climate risks will continue to be a concern.Retail store hours and inventory (hydration products, etc.)This will also have repercussions.
(https://pubmed.ncbi.nlm.nih.gov/42647618/)

Accumulating advocacy talent accelerates policy formation.

  • This section, based on NORML's internship records, showcases policy collaboration at legislative and state summits, as well as analysis of state laws.

Supplying highly specialized personnel isSpeed ​​and quality of regulatory developmentThe market予見可能性This will increase the visibility of the returns on companies' GR (Government Relations) investments.
(https://norml.org/blog/2026/08/28/what-i-learned-from-my-summer-with-norml/)

Diversity and equity are "not synonymous"—Power and distribution in the industry

  • MJBizDaily reported that "recovering from losses requires the affected communities to..."Decision-making powerThe need to have [something] was raised.

Social equity design is,License allocation, reinvestment of tax revenue, employmentThis is reflected in, and as a resultMarket entry costswithLocally established demandThis will have an impact.
(https://mjbizdaily.com/news/diversity-is-not-the-same-as-equity-in-us-cannabis-industry/617799/)

Today's highlights (3 points)

  1. DEA reclassificationOver 70%" and the expectation,Insufficient trading volumeThe gap between reality and the "promise." The risks until the next report areVolatility increased.
  2. In British healthcareTHC over 22% = 85%Overemphasis on high potency. Product portfolioHigh value-addedAnd, inspection and educationIncreased costsThey are two sides of the same coin.
  3. Dutch41 %As seen in the issue of ownership,Cross-industry capitalThe influence of global capital policy on price, supply, and regulation.design trianglePlease rate it.

Reference links (sources)

Collection List

Share this article

    RANKING

    Choose from popular products

    Top of page